Showing results (2451-2460 of 2,573) with videos related to

Sort By:
Pageof 258
Nature Communications|July 23, 2014
Disrupted auto-regulation of the spliceosomal gene SNRPB causes cerebro-costo-mandibular syndromeDanielle C Lynch, Timothée Revil, Jeremy Schwartzentruber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2020
Phase IB Study of Osimertinib in Combination with Navitoclax in EGFR-mutant NSCLC Following Resistance to Initial EGFR Therapy (ETCTN 9903)Erin M Bertino, Ryan D Gentzler, Sarah Clifford, et al.
JTO Clinical and Research Reports|February 16, 2024
The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLCTejas Patil, Alyse Staley, Yunan Nie, et al.
American Journal of Respiratory and Critical Care Medicine|February 23, 2019
Noninvasive Imaging Biomarker Identifies Small Airway Damage in Severe Chronic Obstructive Pulmonary DiseaseDragoş M Vasilescu, Fernando J Martinez, Nathaniel Marchetti, et al.
Current Biology : CB|February 7, 2018
Inherent limits of light-level geolocation may lead to over-interpretationSimeon Lisovski, Heiko Schmaljohann, Eli S Bridge, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 2, 2026
Cardiovascular Disease Risk and Falls in Men and Women Living with and Without HIV in MACS/WIHS Combined Cohort StudyElizabeth Vásquez, Mark H Kuniholm, Allison A Appleton, et al.
The Lancet. Oncology|March 15, 2016
Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trialDong-Wan Kim, Ranee Mehra, Daniel S W Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2014
FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologiesMurry W Wynes, Trista K Hinz, Dexiang Gao, et al.
Genes|May 15, 2019
Outcome Definition Influences the Relationship Between Genetic Polymorphisms of ERCC1, ERCC2, SLC22A2 and Cisplatin Nephrotoxicity in Adult Testicular Cancer PatientsZulfan Zazuli, Leila S Otten, Britt I Drögemöller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2013
First-in-human phase I trial of two schedules of OSI-930, a novel multikinase inhibitor, incorporating translational proof-of-mechanism studiesTimothy A Yap, Hendrik-Tobias Arkenau, D Ross Camidge, et al.
Pageof 258